- Home
- TYRA vs EBTC Comparison
TYRA vs EBTC Comparison
Compare TYRA & EBTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- EBTC
- Stock Information
- Founded
- TYRA 2018
- EBTC 1989
- Country
- TYRA United States
- EBTC United States
- Employees
- TYRA 38
- EBTC N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- EBTC Major Banks
- Sector
- TYRA Health Care
- EBTC Finance
- Exchange
- TYRA Nasdaq
- EBTC Nasdaq
- Market Cap
- TYRA 666.4M
- EBTC 533.2M
- IPO Year
- TYRA 2021
- EBTC 2005
- Fundamental
- Price
- TYRA $13.17
- EBTC $42.45
- Analyst Decision
- TYRA Strong Buy
- EBTC
- Analyst Count
- TYRA 6
- EBTC 0
- Target Price
- TYRA $30.50
- EBTC N/A
- AVG Volume (30 Days)
- TYRA 247.2K
- EBTC 33.0K
- Earning Date
- TYRA 03-18-2025
- EBTC 01-28-2025
- Dividend Yield
- TYRA N/A
- EBTC 2.31%
- EPS Growth
- TYRA N/A
- EBTC 0.32
- EPS
- TYRA N/A
- EBTC 3.12
- Revenue
- TYRA N/A
- EBTC $168,758,000.00
- Revenue This Year
- TYRA N/A
- EBTC N/A
- Revenue Next Year
- TYRA N/A
- EBTC N/A
- P/E Ratio
- TYRA N/A
- EBTC $13.89
- Revenue Growth
- TYRA N/A
- EBTC 4.53
- 52 Week Low
- TYRA $11.89
- EBTC $22.60
- 52 Week High
- TYRA $29.60
- EBTC $44.41
- Technical
- Relative Strength Index (RSI)
- TYRA 43.64
- EBTC 50.84
- Support Level
- TYRA $12.27
- EBTC $42.38
- Resistance Level
- TYRA $13.79
- EBTC $43.95
- Average True Range (ATR)
- TYRA 0.71
- EBTC 1.14
- MACD
- TYRA 0.03
- EBTC -0.17
- Stochastic Oscillator
- TYRA 51.09
- EBTC 54.63
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).
About EBTC Enterprise Bancorp Inc
Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.